Lignospan Special (Epinephrine, Anhydrous Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, preventing the initiation and propagation of action potentials. This interruption stops pain signals from reaching the brain, resulting in a rapid loss of sensation in the targeted area.

The appropriate dose of Lignospan Special is determined by the prescribing clinician based on the procedure, patient size, and site of administration. Healthcare professionals calculate the amount needed to stay within safe lidocaine limits and to achieve the desired duration of anesthesia.

Safety data for Lignospan Special in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Clinicians should weigh potential benefits against risks and consider alternative anesthetic options when treating pregnant or nursing patients.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Compared with lidocaine alone, Lignospan Special adds epinephrine, which causes local vasoconstriction. This prolongs the anesthetic duration, reduces systemic absorption, and minimizes intra‑procedural bleeding, making it preferable for longer or more vascular procedures.

Store Lignospan Special at room temperature, below 25 °C, in its original packaging. Protect the container from moisture, direct sunlight and extreme temperature fluctuations to maintain product stability and potency.

The product is supplied as a sterile solution for injection. It is administered by infiltration, perineural, or submucosal injection using standard aseptic techniques, allowing the clinician to target the specific tissue or nerve requiring anesthesia.

Serious risks include allergic reactions such as anaphylaxis, cardiovascular events like hypertension, tachycardia or arrhythmias due to epinephrine, and central nervous system toxicity (e.g., seizures) from excessive lidocaine absorption. Immediate medical attention is required if these occur.

Patients with known hypersensitivity to lidocaine, epinephrine, or any component of the formulation should avoid it. It is also contraindicated in individuals with severe uncontrolled hypertension, significant cardiac arrhythmias, or those taking monoamine oxidase inhibitors.